von Schulthess GK - Search Results

1

F-18 FDG whole-body PET for the assessment of disease activity in patients with rheumatoid arthritis.

Goerres GW, Forster A, Uebelhart D, Seifert B, Treyer V, Michel B, von Schulthess GK, Kaim AH. Goerres GW, et al. Among authors: von schulthess gk. Clin Nucl Med. 2006 Jul;31(7):386-90. doi: 10.1097/01.rlu.0000222678.95218.42. Clin Nucl Med. 2006. PMID: 16785804 Clinical Trial.

2

Radioimmuno positron emission tomography with monoclonal antibodies: a new approach to quantifying in vivo tumour concentration and biodistribution for radioimmunotherapy.

Westera G, Reist HW, Buchegger F, Heusser CH, Hardman N, Pfeiffer A, Sharma HL, von Schulthess GK, Mach JP. Westera G, et al. Among authors: von schulthess gk. Nucl Med Commun. 1991 May;12(5):429-37. Nucl Med Commun. 1991. PMID: 2067747

3

Malignant melanoma: staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose.

Steinert HC, Huch Böni RA, Buck A, Böni R, Berthold T, Marincek B, Burg G, von Schulthess GK. Steinert HC, et al. Among authors: von schulthess gk. Radiology. 1995 Jun;195(3):705-9. doi: 10.1148/radiology.195.3.7753998. Radiology. 1995. PMID: 7753998

4

Carbon-11 and iodine-123 labelled iomazenil: a direct PET-SPET compari son.

Westera G, Buck A, Burger C, Leenders KL, von Schulthess GK, Schubiger AP. Westera G, et al. Among authors: von schulthess gk. Eur J Nucl Med. 1996 Jan;23(1):5-12. doi: 10.1007/BF01736983. Eur J Nucl Med. 1996. PMID: 8586102

5

Whole-body PET: physiological and artifactual fluorodeoxyglucose accumulations.

Engel H, Steinert H, Buck A, Berthold T, Huch Böni RA, von Schulthess GK. Engel H, et al. Among authors: von schulthess gk. J Nucl Med. 1996 Mar;37(3):441-6. J Nucl Med. 1996. PMID: 8772641 Free article.

6

Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography.

Stumpe KD, Urbinelli M, Steinert HC, Glanzmann C, Buck A, von Schulthess GK. Stumpe KD, et al. Among authors: von schulthess gk. Eur J Nucl Med. 1998 Jul;25(7):721-8. doi: 10.1007/s002590050275. Eur J Nucl Med. 1998. PMID: 9662594 Clinical Trial.

7

Planar coincidence scintigraphy and PET in staging malignant melanoma.

Steinert HC, Voellmy DR, Trachsel C, Bicik I, Buck A, Huch RA, von Schulthess GK. Steinert HC, et al. Among authors: von schulthess gk. J Nucl Med. 1998 Nov;39(11):1892-7. J Nucl Med. 1998. PMID: 9829578 Free article.

8

FDG PET-negative liver metastases of a malignant melanoma and FDG PET-positive hurthle cell tumor of the thyroid.

Wiesner W, Engel H, von Schulthess GK, Krestin GP, Bicik I. Wiesner W, et al. Among authors: von schulthess gk. Eur Radiol. 1999;9(5):975-8. doi: 10.1007/s003300050779. Eur Radiol. 1999. PMID: 10370003

9

Value of (18F)-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma.

Kubik-Huch RA, Dörffler W, von Schulthess GK, Marincek B, Köchli OR, Seifert B, Haller U, Steinert HC. Kubik-Huch RA, et al. Among authors: von schulthess gk. Eur Radiol. 2000;10(5):761-7. doi: 10.1007/s003300051000. Eur Radiol. 2000. PMID: 10823629

10

Chronic osteomyelitis of the femur: value of PET imaging.

Robiller FC, Stumpe KD, Kossmann T, Weisshaupt D, Bruder E, von Schulthess GK. Robiller FC, et al. Among authors: von schulthess gk. Eur Radiol. 2000;10(5):855-8. doi: 10.1007/s003300051019. Eur Radiol. 2000. PMID: 10823648

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

345 results

Search Page

Filters